Topics
High-grade gliomas | Treatment | Immunotherapy | CAR-T-Cells
Home > Publications > Topics > High-grade gliomas > Treatment > Immunotherapy > CAR-T-Cells
Gallus M, Young JS, Cook Quackenbush S, Khasraw M, de Groot J,
Okada H.
Chimeric antigen receptor
T-cell therapy in patients with malignant glioma-From
neuroimmunology to clinical trial design considerations.
Neuro
Oncol. 2024 Oct 24:noae203. doi:
10.1093/neuonc/noae203. PMID:
39450490. Review. ˍ
Grewal EP, Nahed BV, Carter BS,
Gerstner ER, Curry WT, Maus MV, Choi BD.
Clinical
progress in the development of CAR T cells to treat malignant
glioma.
J
Neurooncol. 2024
Dec 18. doi:
10.1007/s11060-024-04909-7. PMID:
39695004. Interventional; Review˰ ˍ
Park S, Maus MV, Choi BD.
CAR-T cell
therapy for the treatment of adult high-grade gliomas.
NPJ
Precis Oncol. 2024 Dec 19;8(1):279. doi:
10.1038/s41698-024-00753-0. PMID:
39702579. Review. ˍ